The Pediatric Research Equity Act (PREA) is a legislation enacted by the United States Congress in 2003, which mandates that pharmaceutical companies evaluate the safety and effectiveness of new drugs and biologics in pediatric populations. This law aims to ensure that children have access to medications that are specifically tested for their use, as they often respond differently to drugs than adults.
